ANGPT1 and ischemia: When evaluating the angio-vasculogenic properties of hAMCs by determining their therapeutic effects in experimental ischemia, significantly higher levels of pro-angiogenic genes were observed, particularly VEGF-A, angiopoietin-1 (ANG-1), HGF, and FGF-2, compared to adipose-derived mesenchymal stem cells (ADMSC).